Interferon inhibits transformation by murine sarcoma viruses before integration of provirus.
Neoplastic transformation by C-type retroviruses requires synthesis of a DNA copy (the provirus) of the RNA genome and its integration into the host cell DNA. We have previously shown that interferon (IFN) can stably prevent transformation of murine fibroblasts by the Kirsten strain of murine sarcoma virus (KiMSV), a murine leukaemia virus (MLV). A series of cell clones (IFN clones), isolated in the presence of IFN (10(4) U ml-1) from cultures of NIH-3T3 cells which had been treated with IFN, and then infected with KiMSV (KiMLV) in conditions where every cell was infected, were shown to be phenotypically untransformed. These untransformed cells did not produce virus or contain rescuable KiMSV. However, cells isolated using an identical procedure, but in the absence of IFN, were uniformly transformed and all produced KiMSV (KiMLV) or contained rescuable KiMSV. It was concluded that IFN either prevents synthesis or integration of the provirus, or else that in the presence of IFN the provirus is integrated such that it is not expressed. We now show that five representative clones contain no detectable KiMSV proviral DNA, and also that the initial stages of infection by KiMSV (KiMLV) are inhibited by IFN treatment. IFN seems to act before integration, preventing either the synthesis or the integration of proviral DNA.
D000818:Animals; D002472:Cell Transformation, Viral / Q000187:drug effects*; D002478:Cells, Cultured; D004279:DNA, Viral / Q000032:analysis / Q000096:biosynthesis; D003864:Depression, Chemical; D005814:Genes, Viral; D007372:Interferons / Q000494:pharmacology*; D007708:Kirsten murine sarcoma virus / Q000235:genetics*; D051379:Mice; D009053:Sarcoma Viruses, Murine / Q000235:genetics*; D013997:Time Factors
D004279:DNA, Viral; D007372:Interferons